Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ATIP NASDAQ:BPTH NASDAQ:DFHT NASDAQ:IVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATIPATI Physical Therapy$0.68$0.87$0.01▼$6.59$2.98M-0.159,934 shs1 shsBPTHBio-Path$0.15+1.6%$0.17$0.12▼$3.39$1.27M-0.03197,328 shs11,517 shsDFHTDeerfield Healthcare Technology Acquisitions$0.02$9.43$9.90▼$18.42$331KN/A111,677 shs6,097 shsIVFINVO Fertility$1.84+1.1%$3.31$1.61▼$51.12$1.31M1.993.62 million shs887,806 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATIPATI Physical Therapy0.00%+87.50%-32.50%-25.00%-89.37%BPTHBio-Path+1.60%+4.38%-12.81%+1.67%-90.35%DFHTDeerfield Healthcare Technology Acquisitions0.00%0.00%0.00%0.00%0.00%IVFINVO Fertility+1.10%-17.86%-27.38%-65.93%-94.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATIPATI Physical Therapy0.1243 of 5 stars0.02.00.00.00.01.70.0BPTHBio-Path0.449 of 5 stars0.03.00.00.00.60.01.3DFHTDeerfield Healthcare Technology AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATIPATI Physical Therapy 0.00N/AN/AN/ABPTHBio-Path 0.00N/AN/AN/ADFHTDeerfield Healthcare Technology Acquisitions 0.00N/AN/AN/AIVFINVO Fertility 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATIPATI Physical Therapy$741.86M0.00$3.55 per share0.19($23.96) per share-0.03BPTHBio-PathN/AN/AN/AN/A$0.71 per shareN/ADFHTDeerfield Healthcare Technology AcquisitionsN/AN/AN/AN/A$0.28 per shareN/AIVFINVO Fertility$6.53M0.20N/AN/A($89.58) per share-0.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATIPATI Physical Therapy-$69.79M-$19.42N/A∞N/A-7.79%N/A-3.87%8/6/2025 (Estimated)BPTHBio-Path-$16.08MN/A0.00N/AN/AN/A-2,842.40%-337.48%8/13/2025 (Estimated)DFHTDeerfield Healthcare Technology Acquisitions-$21.51MN/A0.00∞N/AN/AN/AN/AN/AIVFINVO Fertility-$9.10M-$102.18N/A∞N/A-377.73%N/A-88.18%N/ALatest DFHT, ATIP, IVF, and BPTH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/21/2025Q2 2025BPTHBio-Path-$0.40N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATIPATI Physical TherapyN/AN/AN/AN/AN/ABPTHBio-PathN/AN/AN/AN/AN/ADFHTDeerfield Healthcare Technology AcquisitionsN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATIPATI Physical TherapyN/A1.121.12BPTHBio-PathN/A0.860.86DFHTDeerfield Healthcare Technology AcquisitionsN/A0.120.12IVFINVO FertilityN/A0.080.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATIPATI Physical Therapy72.60%BPTHBio-Path5.74%DFHTDeerfield Healthcare Technology Acquisitions89.54%IVFINVO Fertility12.02%Insider OwnershipCompanyInsider OwnershipATIPATI Physical Therapy3.30%BPTHBio-Path0.72%DFHTDeerfield Healthcare Technology AcquisitionsN/AIVFINVO Fertility0.57%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATIPATI Physical Therapy5,6004.41 million4.27 millionNo DataBPTHBio-Path108.31 million5.73 millionOptionableDFHTDeerfield Healthcare Technology AcquisitionsN/A17.97 millionN/ANot OptionableIVFINVO Fertility25720,000716,000No DataDFHT, ATIP, IVF, and BPTH HeadlinesRecent News About These CompaniesINVO Fertility Implements Reverse Stock SplitJuly 24, 2025 | theglobeandmail.comINVO Fertility Announces First Quarter 2025 Financial ResultsMay 20, 2025 | globenewswire.comINVO Fertility To Begin Trading Under New Nasdaq Ticker Symbol 'IVF'April 26, 2025 | nasdaq.comSarasota fertility company changes name, ticker symbolApril 26, 2025 | businessobserverfl.comBNAYA Biosciences spins off cancer drug business 6 months after INVO mergerApril 15, 2025 | fiercebiotech.comFNAYA Biosciences to separate fertility and oncology businesses into distinct operations, changes name to INVO FertilityApril 15, 2025 | msn.comNAYA Biosciences announces strategic decision to separate fertility and oncologyApril 15, 2025 | markets.businessinsider.comNAYA Biosciences Changes Name to INVO Fertility Amid Business SeparationApril 14, 2025 | marketwatch.comNAYA Biosciences Inc trading halted, news pendingMarch 18, 2025 | markets.businessinsider.comNAYA Biosciences to effect 1-for-12 reverse splitMarch 13, 2025 | markets.businessinsider.comNAYA Biosciences supports executive order on fertility treatment accessFebruary 26, 2025 | markets.businessinsider.comLakewood Ranch life sciences firm seeks to raise $9.5M through public offeringJanuary 13, 2025 | businessobserverfl.comBNAYA Biosciences To Raise $9.5 Mln Through Public Offering Of UnitsJanuary 13, 2025 | markets.businessinsider.comNAYA Biosciences to present insights into mode of action of NY-303November 1, 2024 | markets.businessinsider.comNAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular CarcinomaOctober 24, 2024 | globenewswire.comNAYA Biosciences Inc (INVO)October 23, 2024 | investing.comINVO Bioscience changes name, trading symbol after mergerOctober 22, 2024 | businessobserverfl.comBINVO Bioscience confirms name change, new trading symbol following NAYA mergerOctober 22, 2024 | markets.businessinsider.comINVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA BiosciencesOctober 21, 2024 | globenewswire.comInvo Bioscience Inc (INVO) Stock’s -0.02% Decrease This Year: What’s the Story?October 15, 2024 | bovnews.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDFHT, ATIP, IVF, and BPTH Company DescriptionsATI Physical Therapy NYSE:ATIP$0.68 0.00 (0.00%) As of 07/30/2025ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.Bio-Path NASDAQ:BPTH$0.15 +0.00 (+1.60%) As of 08/1/2025 02:14 PM EasternBio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.Deerfield Healthcare Technology Acquisitions NASDAQ:DFHTDeerfield Healthcare Technology Acquisitions Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare-related industries in the United States and other developed countries. The company was incorporated in 2020 and is based in New York, New York.INVO Fertility NASDAQ:IVF$1.84 +0.02 (+1.10%) As of 08/1/2025 04:00 PM EasternINVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
